Longevity Health Holdings Statistics
Total Valuation
XAGE has a market cap or net worth of 843,653. The enterprise value is 353,052.
| Market Cap | 843,653 |
| Enterprise Value | 353,052 |
Important Dates
The last earnings date was Friday, November 14, 2025.
| Earnings Date | Nov 14, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
XAGE has 1.78 million shares outstanding. The number of shares has increased by 57.78% in one year.
| Current Share Class | 1.78M |
| Shares Outstanding | 1.78M |
| Shares Change (YoY) | +57.78% |
| Shares Change (QoQ) | +42.46% |
| Owned by Insiders (%) | 6.37% |
| Owned by Institutions (%) | 8.55% |
| Float | 1.67M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 0.58 |
| PB Ratio | -0.21 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | -0.06 |
| EV / Sales | 0.24 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | -0.08 |
Financial Position
The company has a current ratio of 0.42
| Current Ratio | 0.42 |
| Quick Ratio | 0.21 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | -0.14 |
| Interest Coverage | -292.67 |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | -128.26% |
| Return on Invested Capital (ROIC) | n/a |
| Return on Capital Employed (ROCE) | 166.30% |
| Revenue Per Employee | 145,731 |
| Profits Per Employee | -573,634 |
| Employee Count | 15 |
| Asset Turnover | 0.51 |
| Inventory Turnover | 1.19 |
Taxes
| Income Tax | -97,279 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -94.21% in the last 52 weeks. The beta is 0.33, so XAGE's price volatility has been lower than the market average.
| Beta (5Y) | 0.33 |
| 52-Week Price Change | -94.21% |
| 50-Day Moving Average | 0.85 |
| 200-Day Moving Average | 3.52 |
| Relative Strength Index (RSI) | 39.13 |
| Average Volume (20 Days) | 5,278 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, XAGE had revenue of 1.46 million and -5.74 million in losses. Loss per share was -4.96.
| Revenue | 1.46M |
| Gross Profit | 796,116 |
| Operating Income | -5.89M |
| Pretax Income | -5.83M |
| Net Income | -5.74M |
| EBITDA | -5.81M |
| EBIT | -5.89M |
| Loss Per Share | -4.96 |
Balance Sheet
The company has 1.11 million in cash and 618,632 in debt, giving a net cash position of 490,596 or 0.28 per share.
| Cash & Cash Equivalents | 1.11M |
| Total Debt | 618,632 |
| Net Cash | 490,596 |
| Net Cash Per Share | 0.28 |
| Equity (Book Value) | -3.98M |
| Book Value Per Share | -2.23 |
| Working Capital | -4.00M |
Cash Flow
In the last 12 months, operating cash flow was -4.29 million and capital expenditures -14,224, giving a free cash flow of -4.30 million.
| Operating Cash Flow | -4.29M |
| Capital Expenditures | -14,224 |
| Free Cash Flow | -4.30M |
| FCF Per Share | -2.42 |
Margins
| Gross Margin | 54.63% |
| Operating Margin | -404.19% |
| Pretax Margin | -400.30% |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
XAGE does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -57.78% |
| Shareholder Yield | -57.78% |
| Earnings Yield | -679.94% |
| FCF Yield | -510.27% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
The last stock split was on May 14, 2025. It was a reverse split with a ratio of 0.0333333.
| Last Split Date | May 14, 2025 |
| Split Type | Reverse |
| Split Ratio | 0.0333333 |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 3 |